全文获取类型
收费全文 | 42903篇 |
免费 | 5930篇 |
国内免费 | 1073篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 532篇 |
妇产科学 | 464篇 |
基础医学 | 4680篇 |
口腔科学 | 684篇 |
临床医学 | 3683篇 |
内科学 | 1873篇 |
皮肤病学 | 434篇 |
神经病学 | 980篇 |
特种医学 | 1989篇 |
外国民族医学 | 76篇 |
外科学 | 5396篇 |
综合类 | 5748篇 |
现状与发展 | 7篇 |
一般理论 | 1篇 |
预防医学 | 1764篇 |
眼科学 | 138篇 |
药学 | 2467篇 |
33篇 | |
中国医学 | 846篇 |
肿瘤学 | 17965篇 |
出版年
2024年 | 103篇 |
2023年 | 671篇 |
2022年 | 1125篇 |
2021年 | 2183篇 |
2020年 | 2011篇 |
2019年 | 1766篇 |
2018年 | 1648篇 |
2017年 | 1751篇 |
2016年 | 1929篇 |
2015年 | 2242篇 |
2014年 | 2944篇 |
2013年 | 3110篇 |
2012年 | 2449篇 |
2011年 | 2603篇 |
2010年 | 1980篇 |
2009年 | 1842篇 |
2008年 | 1878篇 |
2007年 | 1963篇 |
2006年 | 1951篇 |
2005年 | 1744篇 |
2004年 | 1450篇 |
2003年 | 1409篇 |
2002年 | 1145篇 |
2001年 | 1044篇 |
2000年 | 816篇 |
1999年 | 733篇 |
1998年 | 602篇 |
1997年 | 576篇 |
1996年 | 485篇 |
1995年 | 433篇 |
1994年 | 324篇 |
1993年 | 286篇 |
1992年 | 250篇 |
1991年 | 248篇 |
1990年 | 184篇 |
1989年 | 180篇 |
1988年 | 162篇 |
1987年 | 146篇 |
1986年 | 136篇 |
1985年 | 203篇 |
1984年 | 189篇 |
1983年 | 126篇 |
1982年 | 154篇 |
1981年 | 149篇 |
1980年 | 126篇 |
1979年 | 95篇 |
1978年 | 79篇 |
1977年 | 70篇 |
1976年 | 78篇 |
1973年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 343 毫秒
71.
The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites 总被引:1,自引:0,他引:1
MCA, CA 15-3, CEA and CA 125 were determined in the serum of 49 patients with metastatic breast cancer and 38 patients with metastatic adenocarcinoma of other primary sites. By using the 99th percentile of the normal value distribution as the cut-off point, the positive predictive value (PV+) was found to be 85% (95% CI 76-94) for MCA, and 71% (95% CI 61-81) for CA 15-3. When receiver-operating-characteristic (ROC) curves were constructed, the PV+ for CA 15-3 was increased to 82% (95% CI 72-92), using 60 U ml-1 as the cut-off point. With the exception of two patients who had a slightly elevated MCA, MCA and CA 15-3 identified the same patients with breast cancer. By combining a positive MCA or CA 15-3 with a negative CEA and CA 125, further improvement of the PV+ could be achieved; 100% (95% CI 91-100). We conclude that MCA and CA 15-3 may play a useful role in discrimination between patients with metastatic breast cancer and those with adenocarcinoma of other primary sites. 相似文献
72.
A case of ultrastructurally confirmed myoepithelioma of the breast studied by fine-needle aspiration biopsy is reported. Aspirated tumor cells were spindle-shaped with well-defined cytoplasm and oval nuclei showing no remarkable nuclear pleomorphism. They were seen mainly in irregular bundles with strong cellular cohesiveness. Their cytoplasm contained S-100 protein demonstrated by the peroxidase antiperoxidase staining technique. 相似文献
73.
明玉华 《现代中西医结合杂志》2007,16(27):3940-3942
目的探讨影响乳腺癌患者预后的因素,协助临床制定手术方式及术后治疗方案。方法选择80例各型乳腺癌患者的标本,应用免疫组化SP方法,检测乳腺癌组织中癌基因BcL-2、Bax及黏附因子CD44V6的表达情况。结果乳腺癌中BcL-2、Bax及CD44V6的表达情况与肿瘤组织学分级、瘤体直径。有无转移及患者术后存活时间均有显著性相关(P<0.05或0.01)。结论BcL-2高表达、Bax低表达、CD44V6低表达的患者组织学分级好,肿瘤体积小,淋巴结转移少,术后存活时间长,这部分患者可做肿物扩大切除而保留乳房或即使已做乳房切除,术后也可减少放疗及化疗剂量。 相似文献
74.
K. OKAMURA I. KOBAYASHI K. MATSUO T. KIYOSHIMA K. YAMAMOTO A. MIYOSHI & H. SAKAI 《Histopathology》1997,31(6):540-548
Aims:
The purpose of this study is to examine the relationship between immunohistochemical localization of cathepsin D (CD), proliferating cell nuclear antigen (PCNA) and epidermal growth factor receptor (EGF-R) in 65 cases of breast carcinoma in Japanese women and traditional prognostic factors such as histological grade, lymph node status, mitotic rate and clinical stage, in order to possibly identify some indicator(s) that may be specifically associated with prognosis.
Methods and results:
Serial sections of 5-μm thick were cut from the archival formalin-fixed, paraffin-embedded tissue blocks, and processed for CD, PCNA and EGF-R immunostaining. The results were analysed by computer-based image analysis system. All samples showed a positive immunoreaction for cathepsin D in both the parenchyma and stroma. However, the staining area and intensity varied from cell to cell in the parenchyma and stroma as well as among samples. Subsequently, the evaluation of immunostaining for CD was separately performed in both the parenchyma and stroma (CDpar and CDstr, respectively) and the combination of both components (CDtotal). PCNA and EGF-R showed positive immunostaining almost exclusively in the parenchymal component of the carcinoma tissue specimens. CDtotal significantly correlated with the histological grade, PCNA index (PI), mitotic rate (MR), EGF-R and lymph node metastasis. Significant correlation was also demonstrated between CDpar and the histological grade, EGF-R and lymph node metastasis, or between CDstr and MR, EGF-R and lymph node metastasis. EGF-R correlated highly with the histological grade, MR score, lymph node metastases and recurrence-free survival.
Conclusions:
Both the CD parameters and EGF-R are valuable indicators for predicting the biological behaviour of human breast carcinoma. 相似文献
75.
Abstract: A prospective study was performed to determine whether low-density lipoprotein (LDL) apheresis, when performed only immediately before and after percutaneous transluminal coronary angioplasty (PTCA), is effective in preventing restenosis of coronary artery lesions following PTCA. Thirty-six patients with coronary heart disease (CHD) and hypercholesterolemia were divided into 2 groups. The 9 patients in the LDL group underwent LDL-apheresis 1 day before and 5 days after PTCA while the 27 patients of the control group underwent PTCA but did not undergo LDL-apheresis. Follow-up coronary angiography (CAG) was performed 4 months after PTCA. The rate of restenosis of coronary artery lesions was significantly lower in the LDL group (0%) than in the control group (30%). These findings suggest that LDL-apheresis, when performed before and after PTCA, is effective in preventing restenosis of coronary artery lesions in patients with CHD and hypercholesterolemia. 相似文献
76.
A. G. Douglas-Jones H. Navabi J. M. Morgan B. Jasani 《Virchows Archiv : an international journal of pathology》1997,430(5):373-379
Immunocytochemically detectable MT and p53 have been found more commonly in comedo DCIS of the breast with high-grade cytology.
The aim of this study is to confirm these findings and to investigate the relationship between MT and p53 in a single large
series of cases of DCIS of the breast. To this end, 127 cases of DCIS were classified histologically according to architecture,
cytonuclear differentiation (grade), presence and extent of intraduct necrosis, and using the Van Nuys system. Sections were
immunostained for p53 and MT (E9) using established techniques, and the extent and intensity of staining were assessed semi-quantitively.
The results confirmed that there was generally more MT and p53 positivity in poorly differentiated (grade 3) DCIS with extensive
necrosis and that MT expression was greater in grade 2 lesions than p53 expression. However, overall there was no statistically
significant correlation between p53 and MT staining. The results indicate that MT and p53 overexpression may arise from independent
mechanisms in early breast neoplasia.
Received: 3 July 1996 / Accepted: 5 November 1996 相似文献
77.
在欧美,乳腺肿块针吸细胞学诊断于70年代就已得到了成功的应用。近年来国内的一些研究也证实其实用价值。为了进一步提高乳腺细胞学诊断水平,现将我院针吸细胞学诊断乳腺肿块281例中由病理证实的118例进行总结分析。1 材料与方法1.1 临床资料:1986年12月~1990年2月采用针吸细胞学检查诊断乳腺肿块281例,其中118例施行手术并获得病理组织学的证实。细胞学诊断以原始报告为准。女 相似文献
78.
Franco Rilke M. D. F. R. C. Umberto Veronesi M. D. Alberto Luini M. D. Cristina Brambilla M. D. Viviana Galimberti M. D. Stefano Zurrida M. D. Silvana Pilotti M. D. M. I. A. C. Silvana Di Palma M. D. Roberto Zucali M. D. Laura Lozza M. D. 《The breast journal》1996,2(3):176-180
Abstract: Breast conservation surgery is an effective and safe treatment for many breast carcinomas. It may be possible to further limit the extent of resection (or expand the indication for breast conservation) by the application of preoperative chemotherapy and radiotherapy. We explored the feasibility of this in a pilot study.
Seventy-three patients (mean age 48, 63% premenopausal) with confirmed breast cancer, less than 2.5 cm, received chemotherapy (Group A) or chemotherapy plus radiotherapy (Group B) prior to limited resection (tumorectomy). Axillary dissection was always performed. Results: In 6/31 (19%) Group A and 17/42 (40%) Group B patients the tumor was not palpable after preoperative treatment, with complete pathological remission in 1 and 3 cases respectively. Histologic grading, mitosis, cellular alteration, and cellularity evaluations indicated a consistently greater therapeutic effect with chemoradiotherapy than with chemotherapy alone.
In conclusion, radiotherapy appears useful in the preoperative treatment of breast cancer and its use in association with various drug combinations should be further explored. 相似文献
Seventy-three patients (mean age 48, 63% premenopausal) with confirmed breast cancer, less than 2.5 cm, received chemotherapy (Group A) or chemotherapy plus radiotherapy (Group B) prior to limited resection (tumorectomy). Axillary dissection was always performed. Results: In 6/31 (19%) Group A and 17/42 (40%) Group B patients the tumor was not palpable after preoperative treatment, with complete pathological remission in 1 and 3 cases respectively. Histologic grading, mitosis, cellular alteration, and cellularity evaluations indicated a consistently greater therapeutic effect with chemoradiotherapy than with chemotherapy alone.
In conclusion, radiotherapy appears useful in the preoperative treatment of breast cancer and its use in association with various drug combinations should be further explored. 相似文献
79.
80.
Peter M. Ravdin Stephanie Green James H. Doroshow Silvana Martino 《Investigational new drugs》1994,12(4):333-336
Summary Thirty-two eligible patients with advanced metastatic breast cancer who had received no more than 1 prior chemotherapy regimen for metastatic disease (16 had received prior doxorubicin) were treated with piroxantrone at a dose of 120 mg/m2 intravenously every 21 days. In the twenty-seven patients evaluable for response, two partial responses were seen. Toxicities observed were primarily hematologic with grade 3 or greater granulocytopenia occurring in 34% of the patients. One patient developed symptomatic congestive heart failure at a total cumulative dose of 960 mg/m2. We conclude that piroxantrone given at this dose and schedule has minimal activity in patients with metastatic breast cancer. 相似文献